Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q32135911)
Watch
English
Topiramate: a review of preclinical, pharmacokinetic, and clinical data
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
9444441
retrieved
6 July 2017
review article
1 reference
stated in
Europe PubMed Central
title
Topiramate: a review of preclinical, pharmacokinetic, and clinical data
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
9444441
retrieved
6 July 2017
main subject
pharmacokinetics
1 reference
based on heuristic
inferred from title
author name string
W E Rosenfeld
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
9444441
retrieved
6 July 2017
publication date
1 November 1997
1 reference
stated in
Europe PubMed Central
PubMed ID
9444441
retrieved
6 July 2017
published in
Clinical Therapeutics
1 reference
stated in
Europe PubMed Central
PubMed ID
9444441
retrieved
6 July 2017
volume
19
1 reference
stated in
Europe PubMed Central
PubMed ID
9444441
retrieved
6 July 2017
issue
6
1 reference
stated in
Europe PubMed Central
PubMed ID
9444441
retrieved
6 July 2017
page(s)
1294-1308
1 reference
stated in
Europe PubMed Central
PubMed ID
9444441
retrieved
6 July 2017
cites work
Anticonvulsant O-alkyl sulfamates. 2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate and related compounds
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Newer antiepileptic drugs. Towards an improved risk-benefit ratio
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Topiramate: preclinical evaluation of structurally novel anticonvulsant.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New antiepileptic drugs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparative pharmacokinetics of the newer antiepileptic drugs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concomitant therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An investigation into the mechanical and transport properties of aqueous latex films: a new hypothesis for the film-forming mechanism of aqueous dispersion system
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0149-2918(97)80006-9
1 reference
stated in
Europe PubMed Central
PubMed ID
9444441
retrieved
6 July 2017
PubMed ID
9444441
1 reference
stated in
Europe PubMed Central
PubMed ID
9444441
retrieved
6 July 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
